Table 2.
Potentials of ZnONP nanocomposites on the liver function of EAC-challenged mice
| Conjugates | ALT (U/L) | AST (U/L) |
|---|---|---|
| Naive | 30.33 ± 5.50 | 95.67 ± 5.13 |
| EAC | 77.98 ± 0.57a | 215.26 ± 9.39a |
| DOX | 80.11 ± 5.55a | 240.43 ± 8.97a,b |
| ZnONPs | 47.47 ± 2.99a,b,c | 298.13 ± 24.49 |
| ZnONPs/DOX | 62.26 ± 5.78a,b,c | 347.60 ± 30.36a,b,c |
| ZnONPs/FA | 58.94 ± 6.98a,b,c | 244.76 ± 25.05a |
| ZnONPs/DOX/FA | 60.20 ± 6.75a,b,c | 237.87 ± 28.33a |
Data were represented as mean ± SD (n = 10). Difference between groups was considered statistically significant at P < 0.05. Note: a,b,c Statistically significant difference as compared to the corresponding means of naive group (a), EAC group (b), the DOX group (c)